Pralatrexate

CAS: 146464-95-1

Ref. 3B-P2645

Produktinformation

• Name: Pralatrexate
• Synonyme: (2S)-2-[4-[1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl]benzamido]pentanedioic Acid, <span class="text-smallcaps">L</span>-Glutamic acid, N-[4-[1-[(2,4-diamino-6-pteridinyl)methyl]-3-butyn-1-yl]benzoyl]-, <span class="text-smallcaps">L</span>-Glutamic acid, N-[4-[1-[(2,4-diamino-6-pteridinyl)methyl]-3-butynyl]benzoyl]-, Folotyn, N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid, N-[4-[1-[(2,4-Diamino-6-pteridinyl)methyl]-3-butyn-1-yl]benzoyl]-<span class="text-smallcaps">L</span>-glutamic acid, N-{4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid, NSC 754230, L-Glutamic acid, N-[4-[1-[(2,4-diamino-6-pteridinyl)methyl]-3-butynyl]benzoyl]-, N-[4-[1-[(2,4-Diamino-6-pteridinyl)methyl]-3-butyn-1-yl]benzoyl]-L-glutamic acid, 10-Propargyl-10-deazaaminopterin, L-Glutamic acid, N-[4-[1-[(2,4-diamino-6-pteridinyl)methyl]-3-butyn-1-yl]benzoyl]-, PDX
• Marke: TCI

Chemische Eigenschaften

• Molekulargewicht: 477.48
• Formel: C₂₃H₂₃N₇O₅
• Reinheit: >98.0%(HPLC)
• Farbe/Form: White to Light yellow powder to crystal